Celyad Oncology SA revenue for the last year amounted to 112.58 k USD, the most of which — 112.58 k USD — came from its highest performing source at the moment, Cardiology, the year earlier bringing 6.12 k USD. The greatest contribution to the revenue figure was made by Europe and United States — last year it brought Celyad Oncology SA 112.58 k USD, and the year before that — 6.12 k USD.